Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (4) , 801-810
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (PI-0411-2014)
- Ministero della Salute (RF-2016-02362422)
- AbbVie
- Gilead Sciences
- Secretaría de Estado de Investigacion, Desarrollo e Innovacion
- Deutsches Zentrum für Infektionsforschung (TTU 05.809)
This publication has 41 references indexed in Scilit:
- Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A ProteinAntimicrobial Agents and Chemotherapy, 2016
- Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free RegimensGastroenterology, 2016
- The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a RepliconsAntimicrobial Agents and Chemotherapy, 2016
- The importance of resistance to direct antiviral drugs in HCV infection in clinical practiceJournal of Hepatology, 2016
- L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B SubstitutionsThe Journal of Infectious Diseases, 2015
- O005 : Retreatment of patients who failed 8 or 12 weeks of ledipasvir/sofosbuvir-based regimens with ledipasvir/sofosbuvir for 24 weeksJournal of Hepatology, 2015
- Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European regionAntiviral Research, 2015
- Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical TrialsClinical Infectious Diseases, 2014
- Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2012
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon SystemAntimicrobial Agents and Chemotherapy, 2010